General considerations on the biosafety of virus-derived vectors used in gene therapy and vaccination

Aline Baldo, Eric van den Akker, Hans E Bergmans

  • 1Scientific Institute of Public Health (WIV-ISP), Biosafety and Biotechnology Unit, Rue J. Wytsmanstraat 14, B-1050 Brussels, Belgium. aline.baldo@wiv-isp.be.

Current Gene Therapy
|November 8, 2013
PubMed